![Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E](https://pubs.rsc.org/image/article/2018/CC/c8cc04396e/c8cc04396e-f3_hi-res.gif)
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
![Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram](https://www.researchgate.net/publication/292707470/figure/fig4/AS:669620646187022@1536661411380/Measurement-of-kappa-and-lambda-light-chains-in-free-and-total-assays-Total-light.png)
Measurement of kappa () and lambda () light chains in free and total... | Download Scientific Diagram
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/2-Table1-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/content/117/1/292/F1.large.jpg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology](https://www.frontiersin.org/files/Articles/561146/fimmu-11-02004-HTML/image_m/fimmu-11-02004-g001.jpg)
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology
![Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology](https://www.frontiersin.org/files/Articles/219574/fimmu-07-00388-HTML-r1/image_m/fimmu-07-00388-g004.jpg)
Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology](https://www.frontiersin.org/files/Articles/219574/fimmu-07-00388-HTML-r1/image_m/fimmu-07-00388-g001.jpg)
Frontiers | Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions | Immunology
![Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML Biomedicines | Free Full-Text | Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions | HTML](https://www.mdpi.com/biomedicines/biomedicines-08-00319/article_deploy/html/images/biomedicines-08-00319-g006-550.jpg)